ProShare Advisors LLC lowered its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 8.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,934,035 shares of the company’s stock after selling 170,332 shares during the quarter. ProShare Advisors LLC’s holdings in Colgate-Palmolive were worth $165,012,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Virginia Estate & Retirement Planning Advisors Inc. boosted its stake in Colgate-Palmolive by 1,409.1% during the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock valued at $28,000 after buying an additional 310 shares during the last quarter. Parvin Asset Management LLC purchased a new stake in Colgate-Palmolive in the 2nd quarter worth about $32,000. Park Place Capital Corp boosted its holdings in Colgate-Palmolive by 55.5% during the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after acquiring an additional 127 shares during the period. Gould Capital LLC grew its holdings in shares of Colgate-Palmolive by 38.7% in the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after purchasing an additional 115 shares during the last quarter. Finally, Montgomery Financial Services LLC purchased a new position in shares of Colgate-Palmolive during the second quarter worth approximately $36,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive News Summary
Here are the key news stories impacting Colgate-Palmolive this week:
- Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
- Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
- Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
- Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
- Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis
Colgate-Palmolive Trading Up 2.4%
Shares of Colgate-Palmolive stock opened at $95.35 on Friday. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The company has a fifty day simple moving average of $89.54 and a 200-day simple moving average of $89.65. The stock has a market cap of $76.01 billion, a price-to-earnings ratio of 37.39, a PEG ratio of 4.61 and a beta of 0.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.89 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on CL shares. Piper Sandler dropped their target price on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, September 21st. Weiss Ratings lowered Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Sanford C. Bernstein restated a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating on the stock in a research report on Monday, October 5th. Finally, TD Cowen upped their target price on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, August 3rd. Thirteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $98.56.
Insiders Place Their Bets
In other news, Director John T. Cahill sold 4,170 shares of the firm’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the sale, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Noel R. Wallace sold 161,021 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 175,191 shares of company stock valued at $16,110,903 over the last quarter. Company insiders own 0.43% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.
The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.
Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
